Remove Assay Development Remove Production Remove Synthetic Chemistry
article thumbnail

BetterLife Engages Eurofins Discovery for its Next Generation Psychedelics 2-bromo-LSD FDA IND-enabling Pharmacology Studies

The Pharma Data

This approach makes Eurofins Discovery uniquely qualified to fulfill the needed studies for this innovative product. is an emerging biotechnology company engaged in the development and commercialization of next generation psychedelic products for the treatment of mental disorders. About BetterLife Pharma: BetterLife Pharma Inc.

FDA 52